The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Quetiapine Fumarate Market Research Report 2024
Synopsis
Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.
The global Quetiapine Fumarate market was valued at US$ 159.7 million in 2023 and is anticipated to reach US$ 136.4 million by 2030, witnessing a CAGR of -2.2% during the forecast period 2024-2030.
Europe is the largest Quetiapine Fumarate market with about 92% market share. China is follower, accounting for about 2% market share.
The key players are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. Top 3 companies occupied about 74% market share.
This report aims to provide a comprehensive presentation of the global market for Quetiapine Fumarate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quetiapine Fumarate.
Report Scope
The Quetiapine Fumarate market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Quetiapine Fumarate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Quetiapine Fumarate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Segment by Type
Immediate Release Tablets
Extended Release Tablets
Segment by Application
Adult
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Quetiapine Fumarate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Quetiapine Fumarate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.
The global Quetiapine Fumarate market was valued at US$ 159.7 million in 2023 and is anticipated to reach US$ 136.4 million by 2030, witnessing a CAGR of -2.2% during the forecast period 2024-2030.
Europe is the largest Quetiapine Fumarate market with about 92% market share. China is follower, accounting for about 2% market share.
The key players are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. Top 3 companies occupied about 74% market share.
This report aims to provide a comprehensive presentation of the global market for Quetiapine Fumarate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quetiapine Fumarate.
Report Scope
The Quetiapine Fumarate market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Quetiapine Fumarate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Quetiapine Fumarate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Segment by Type
Immediate Release Tablets
Extended Release Tablets
Segment by Application
Adult
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Quetiapine Fumarate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Quetiapine Fumarate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Quetiapine Fumarate Market Overview
1.1 Product Overview and Scope of Quetiapine Fumarate
1.2 Quetiapine Fumarate Segment by Type
1.2.1 Global Quetiapine Fumarate Market Value Comparison by Type (2024-2030)
1.2.2 Immediate Release Tablets
1.2.3 Extended Release Tablets
1.3 Quetiapine Fumarate Segment by Application
1.3.1 Global Quetiapine Fumarate Market Value by Application: (2024-2030)
1.3.2 Adult
1.3.3 Others
1.4 Global Quetiapine Fumarate Market Size Estimates and Forecasts
1.4.1 Global Quetiapine Fumarate Revenue 2019-2030
1.4.2 Global Quetiapine Fumarate Sales 2019-2030
1.4.3 Global Quetiapine Fumarate Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Quetiapine Fumarate Market Competition by Manufacturers
2.1 Global Quetiapine Fumarate Sales Market Share by Manufacturers (2019-2024)
2.2 Global Quetiapine Fumarate Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Quetiapine Fumarate Average Price by Manufacturers (2019-2024)
2.4 Global Quetiapine Fumarate Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Quetiapine Fumarate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Quetiapine Fumarate, Product Type & Application
2.7 Quetiapine Fumarate Market Competitive Situation and Trends
2.7.1 Quetiapine Fumarate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Quetiapine Fumarate Players Market Share by Revenue
2.7.3 Global Quetiapine Fumarate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Quetiapine Fumarate Retrospective Market Scenario by Region
3.1 Global Quetiapine Fumarate Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Quetiapine Fumarate Global Quetiapine Fumarate Sales by Region: 2019-2030
3.2.1 Global Quetiapine Fumarate Sales by Region: 2019-2024
3.2.2 Global Quetiapine Fumarate Sales by Region: 2025-2030
3.3 Global Quetiapine Fumarate Global Quetiapine Fumarate Revenue by Region: 2019-2030
3.3.1 Global Quetiapine Fumarate Revenue by Region: 2019-2024
3.3.2 Global Quetiapine Fumarate Revenue by Region: 2025-2030
3.4 North America Quetiapine Fumarate Market Facts & Figures by Country
3.4.1 North America Quetiapine Fumarate Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Quetiapine Fumarate Sales by Country (2019-2030)
3.4.3 North America Quetiapine Fumarate Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Quetiapine Fumarate Market Facts & Figures by Country
3.5.1 Europe Quetiapine Fumarate Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Quetiapine Fumarate Sales by Country (2019-2030)
3.5.3 Europe Quetiapine Fumarate Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Quetiapine Fumarate Market Facts & Figures by Country
3.6.1 Asia Pacific Quetiapine Fumarate Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Quetiapine Fumarate Sales by Country (2019-2030)
3.6.3 Asia Pacific Quetiapine Fumarate Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Quetiapine Fumarate Market Facts & Figures by Country
3.7.1 Latin America Quetiapine Fumarate Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Quetiapine Fumarate Sales by Country (2019-2030)
3.7.3 Latin America Quetiapine Fumarate Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Quetiapine Fumarate Market Facts & Figures by Country
3.8.1 Middle East and Africa Quetiapine Fumarate Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Quetiapine Fumarate Sales by Country (2019-2030)
3.8.3 Middle East and Africa Quetiapine Fumarate Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Quetiapine Fumarate Sales by Type (2019-2030)
4.1.1 Global Quetiapine Fumarate Sales by Type (2019-2024)
4.1.2 Global Quetiapine Fumarate Sales by Type (2025-2030)
4.1.3 Global Quetiapine Fumarate Sales Market Share by Type (2019-2030)
4.2 Global Quetiapine Fumarate Revenue by Type (2019-2030)
4.2.1 Global Quetiapine Fumarate Revenue by Type (2019-2024)
4.2.2 Global Quetiapine Fumarate Revenue by Type (2025-2030)
4.2.3 Global Quetiapine Fumarate Revenue Market Share by Type (2019-2030)
4.3 Global Quetiapine Fumarate Price by Type (2019-2030)
5 Segment by Application
5.1 Global Quetiapine Fumarate Sales by Application (2019-2030)
5.1.1 Global Quetiapine Fumarate Sales by Application (2019-2024)
5.1.2 Global Quetiapine Fumarate Sales by Application (2025-2030)
5.1.3 Global Quetiapine Fumarate Sales Market Share by Application (2019-2030)
5.2 Global Quetiapine Fumarate Revenue by Application (2019-2030)
5.2.1 Global Quetiapine Fumarate Revenue by Application (2019-2024)
5.2.2 Global Quetiapine Fumarate Revenue by Application (2025-2030)
5.2.3 Global Quetiapine Fumarate Revenue Market Share by Application (2019-2030)
5.3 Global Quetiapine Fumarate Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AstraZeneca Quetiapine Fumarate Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Intas
6.2.1 Intas Corporation Information
6.2.2 Intas Description and Business Overview
6.2.3 Intas Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Intas Quetiapine Fumarate Product Portfolio
6.2.5 Intas Recent Developments/Updates
6.3 TAPI
6.3.1 TAPI Corporation Information
6.3.2 TAPI Description and Business Overview
6.3.3 TAPI Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.3.4 TAPI Quetiapine Fumarate Product Portfolio
6.3.5 TAPI Recent Developments/Updates
6.4 Accord
6.4.1 Accord Corporation Information
6.4.2 Accord Description and Business Overview
6.4.3 Accord Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Accord Quetiapine Fumarate Product Portfolio
6.4.5 Accord Recent Developments/Updates
6.5 Hexal
6.5.1 Hexal Corporation Information
6.5.2 Hexal Description and Business Overview
6.5.3 Hexal Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hexal Quetiapine Fumarate Product Portfolio
6.5.5 Hexal Recent Developments/Updates
6.6 Dr.Reddy's
6.6.1 Dr.Reddy's Corporation Information
6.6.2 Dr.Reddy's Description and Business Overview
6.6.3 Dr.Reddy's Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Dr.Reddy's Quetiapine Fumarate Product Portfolio
6.6.5 Dr.Reddy's Recent Developments/Updates
6.7 Lupin
6.6.1 Lupin Corporation Information
6.6.2 Lupin Description and Business Overview
6.6.3 Lupin Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lupin Quetiapine Fumarate Product Portfolio
6.7.5 Lupin Recent Developments/Updates
6.8 Sun Pharmaceutical
6.8.1 Sun Pharmaceutical Corporation Information
6.8.2 Sun Pharmaceutical Description and Business Overview
6.8.3 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sun Pharmaceutical Quetiapine Fumarate Product Portfolio
6.8.5 Sun Pharmaceutical Recent Developments/Updates
6.9 Hunan Dongting Pharm
6.9.1 Hunan Dongting Pharm Corporation Information
6.9.2 Hunan Dongting Pharm Description and Business Overview
6.9.3 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hunan Dongting Pharm Quetiapine Fumarate Product Portfolio
6.9.5 Hunan Dongting Pharm Recent Developments/Updates
6.10 SuZhou NO.4 Phamaceutical Factory
6.10.1 SuZhou NO.4 Phamaceutical Factory Corporation Information
6.10.2 SuZhou NO.4 Phamaceutical Factory Description and Business Overview
6.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.10.4 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Portfolio
6.10.5 SuZhou NO.4 Phamaceutical Factory Recent Developments/Updates
6.11 Fuan Pharmaceutical
6.11.1 Fuan Pharmaceutical Corporation Information
6.11.2 Fuan Pharmaceutical Quetiapine Fumarate Description and Business Overview
6.11.3 Fuan Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Fuan Pharmaceutical Quetiapine Fumarate Product Portfolio
6.11.5 Fuan Pharmaceutical Recent Developments/Updates
6.12 Zhejiang Supor Pharmaceuticals
6.12.1 Zhejiang Supor Pharmaceuticals Corporation Information
6.12.2 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Description and Business Overview
6.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Portfolio
6.12.5 Zhejiang Supor Pharmaceuticals Recent Developments/Updates
6.13 Zhejiang Huahai Pharmaceutical
6.13.1 Zhejiang Huahai Pharmaceutical Corporation Information
6.13.2 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Description and Business Overview
6.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Portfolio
6.13.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Quetiapine Fumarate Industry Chain Analysis
7.2 Quetiapine Fumarate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Quetiapine Fumarate Production Mode & Process
7.4 Quetiapine Fumarate Sales and Marketing
7.4.1 Quetiapine Fumarate Sales Channels
7.4.2 Quetiapine Fumarate Distributors
7.5 Quetiapine Fumarate Customers
8 Quetiapine Fumarate Market Dynamics
8.1 Quetiapine Fumarate Industry Trends
8.2 Quetiapine Fumarate Market Drivers
8.3 Quetiapine Fumarate Market Challenges
8.4 Quetiapine Fumarate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
